国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Yersinia pseudotuberculosis serotype O:3 tRNA uridine 5-carboxymethylaminomethyl modification enzyme MnmG (mnmG), partial CSB-YP541169YAX
CSB-EP541169YAX
CSB-BP541169YAX
CSB-MP541169YAX
CSB-EP541169YAX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pseudotuberculosis serotype O:3 Acid shock protein (asr) CSB-YP541170YAX
CSB-EP541170YAX
CSB-BP541170YAX
CSB-MP541170YAX
CSB-EP541170YAX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pseudotuberculosis serotype O:3 UPF0249 protein YPK_1148 (YPK_1148) CSB-YP541171YAX
CSB-EP541171YAX
CSB-BP541171YAX
CSB-MP541171YAX
CSB-EP541171YAX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pseudotuberculosis serotype O:3 DNA repair protein recO (recO) CSB-YP541172YAX
CSB-EP541172YAX
CSB-BP541172YAX
CSB-MP541172YAX
CSB-EP541172YAX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pseudotuberculosis serotype O:3 Serine--tRNA ligase (serS) CSB-YP541173YAX
CSB-EP541173YAX
CSB-BP541173YAX
CSB-MP541173YAX
CSB-EP541173YAX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pseudotuberculosis serotype O:3 ATP synthase gamma chain (atpG) CSB-YP541174YAX
CSB-EP541174YAX
CSB-BP541174YAX
CSB-MP541174YAX
CSB-EP541174YAX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pseudotuberculosis serotype O:3 N-acetylmuramic acid 6-phosphate etherase (murQ) CSB-YP541175YAX
CSB-EP541175YAX
CSB-BP541175YAX
CSB-MP541175YAX
CSB-EP541175YAX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pseudotuberculosis serotype O:3 Peptidase B (pepB) CSB-YP541176YAX
CSB-EP541176YAX
CSB-BP541176YAX
CSB-MP541176YAX
CSB-EP541176YAX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pseudotuberculosis serotype O:3 Nucleoid-associated protein YPK_2796 (YPK_2796) CSB-YP541177YAX
CSB-EP541177YAX
CSB-BP541177YAX
CSB-MP541177YAX
CSB-EP541177YAX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pseudotuberculosis serotype O:3 Probable lipid kinase YegS-like (YPK_1324) CSB-YP541178YAX
CSB-EP541178YAX
CSB-BP541178YAX
CSB-MP541178YAX
CSB-EP541178YAX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pseudotuberculosis serotype O:3 UPF0370 protein YPK_1370 (YPK_1370), partial CSB-YP541179YAX
CSB-EP541179YAX
CSB-BP541179YAX
CSB-MP541179YAX
CSB-EP541179YAX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pseudotuberculosis serotype O:3 UPF0194 membrane protein YPK_2900 (YPK_2900) CSB-YP541180YAX
CSB-EP541180YAX
CSB-BP541180YAX
CSB-MP541180YAX
CSB-EP541180YAX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia cenocepacia GTPase Der (der) CSB-YP541181BXQ
CSB-EP541181BXQ
CSB-BP541181BXQ
CSB-MP541181BXQ
CSB-EP541181BXQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia cenocepacia 30S ribosomal protein S18 (rpsR) CSB-YP541182BXQ
CSB-EP541182BXQ
CSB-BP541182BXQ
CSB-MP541182BXQ
CSB-EP541182BXQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia cenocepacia UPF0061 protein Bcenmc03_1931 (Bcenmc03_1931), partial CSB-YP541183BXQ
CSB-EP541183BXQ
CSB-BP541183BXQ
CSB-MP541183BXQ
CSB-EP541183BXQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia cenocepacia 50S ribosomal protein L7/L12 (rplL) CSB-YP541184BXQ
CSB-EP541184BXQ
CSB-BP541184BXQ
CSB-MP541184BXQ
CSB-EP541184BXQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia cenocepacia 50S ribosomal protein L4 (rplD) CSB-YP541185BXQ
CSB-EP541185BXQ
CSB-BP541185BXQ
CSB-MP541185BXQ
CSB-EP541185BXQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia cenocepacia 50S ribosomal protein L29 (rpmC) CSB-YP541186BXQ
CSB-EP541186BXQ
CSB-BP541186BXQ
CSB-MP541186BXQ
CSB-EP541186BXQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia cenocepacia 50S ribosomal protein L6 (rplF) CSB-YP541187BXQ
CSB-EP541187BXQ
CSB-BP541187BXQ
CSB-MP541187BXQ
CSB-EP541187BXQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia cenocepacia 50S ribosomal protein L15 (rplO) CSB-YP541188BXQ
CSB-EP541188BXQ
CSB-BP541188BXQ
CSB-MP541188BXQ
CSB-EP541188BXQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達載體的選擇、表達蛋白的長度(全長或部分)、是否帶標簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達載體?

表達載體是一種DNA分子,它攜帶特定的基因進入宿主細胞,并利用細胞的蛋白質(zhì)合成機制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達載體可使外源基因在宿主細胞中高效表達,經(jīng)過多年的發(fā)展,表達載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達載體。

第三條:如何表達具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.jhhuazhong.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達服務(wù),您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>